nextGENE Capital - Investor Profile and Portfolio

AmerisourceBergen Corporation is one of the world’s largest pharmaceutical services companies serving global markets with a focus on the pharmaceutical supply chain. Servicing both pharmaceutical manufacturers and healthcare providers, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. Their scale, their position in the healthcare industry, and the value they bring to the channel have all helped their business continue to succeed. Headquartered in Valley Forge, PA, AmerisourceBergen has locations around the world. In the US, we handle about 20% of all of the pharmaceuticals sold and distributed throughout the country. They strive to take costs out of the healthcare system by using their scale and efficient operations to drive value for their customers. In addition to delivering pharmaceuticals on a just-in-time basis to tens of thousands of healthcare providers every day, they provide business support and consulting services to help their customers focus on their key strength—caring for patients. AmerisourceBergen is committed to the safety and security of the nation’s pharmaceutical supply chain. They purchase all branded and generic pharmaceuticals only directly from the product’s manufacturer, except in the rare instance that they are required to do otherwise either by the manufacturer or a government agency. In 2022, the company recorded annual revenues of $247.54B and a net profit of $1.62B